16 research outputs found
Antiresonant Reflecting Guidance and Mach-Zender Interference in Cascaded Hollow-Core Fibers for Multi-Parameter Sensing
We propose and demonstrate a cascaded hollow-core fiber (HCF) device for multi-parameter sensing based on the combination of antiresonant reflecting guidance (ARRG) and Mach-Zender interference (MZI). The device was fabricated by splicing two sections of HCF together. Two sets of fringes, which have different free spectral ranges, were generated from ARRG and MZI, respectively, and were aliasing in the transmission spectrum. The two sets of fringes were then separated using a band pass filter and a Gaussian fitting technique. The wavelengths at two transmission loss dips formed by ARRG and MZI exhibit a temperature sensitivity of 14.1 and 28.5 pm/°C, and a strain sensitivity of 0.4 and −0.8 pm/με, respectively. By using a crossing matrix with differences sensitivities, the cross-sensitivity between temperature and strain can be solved. The gas pressure response of the cascaded HCF device was also tested up to 300 °C, and linear relationships between the gas pressure sensitivities and temperature were found, which can be used in gas pressure application in various temperatures. Moreover, the proposed cascaded HCF sensor is compact, low cost, and simple for fabrication, and hence offers a promising way for the simultaneous measurement of multiple parameters, such as temperature, strain, and gas pressure
High-Efficiency Inscription of Fiber Bragg Grating Array with High-Energy Nanosecond-Pulsed Laser Talbot Interferometer
Red Shift of Side-Polished Fiber Surface Plasmon Resonance Sensors With Silver Coating and Inhibition by Gold Plating
Ladderlike Conical Micropillars Facilitating Underwater Gas-Bubble Manipulation in an Aqueous Environment
High-Sensitivity Gas-Pressure Sensor Based on Fiber-Tip PVC Diaphragm Fabry–Pérot Interferometer
Prevalence and clinical characteristics of atrial fibrillation in hospitalized patients with coronary artery disease and hypertension: a cross-sectional study from 2008 to 2018
Abstract. Background:. The clinical characteristics of patients with the comorbidities of hypertension and coronary artery disease (HT-CAD) and atrial fibrillation (AF) are largely unknown. This study aimed to investigate the prevalence of AF in patients with HT-CAD and clinical characteristics of patients with both HT-CAD and AF.
Methods:. This cross-sectional study was conducted in Chinese People's Liberation Army General Hospital in Beijing, China, and included 20,747 inpatients with HT-CAD with or without AF from August 2008 to July 2018. We examined the overall prevalence, clinical characteristics, comorbidity profiles, treatment patterns, and blood pressure (BP) control of patients with both HT-CAD and AF. Multivariate logistic regression was used to investigate the associations of cardiovascular risk factors with AF in patients with HT-CAD.
Results:. The overall prevalence of AF in patients with HT-CAD was 4.87% (1011/20,747), and this increased with age; to be specific, the prevalence in women and men increased from 0.78% (2/255) and 1.02% (26/2561) at the age of <50 years to 8.73% (193/2210) and 10.28% (298/2900) at the age of ≥70 years, respectively. HT-CAD patients who had AF had a higher prevalence of cardiovascular-related comorbidities than those without AF. Multivariate logistic regression showed that age, gender (male), body mass index, heart failure, and chronic kidney disease were independently associated with the risk of AF in patients with HT-CAD. For those with both HT-CAD and AF, 73.49% (743/1011) had a CHA2DS2-VASc score of ≥4, and only about half of them had the BP controlled at <140/90 mmHg, which indicated a high risk of thromboembolism and stroke. The use of oral anticoagulation increased during the study period (10.00% [20/200] in 2008 to 2011 vs. 30.06% [159/529] in 2015 to 2018, P < 0.01), but remained at a relatively low level.
Conclusions:. AF is highly prevalent among patients with HT-CAD. Patients with both HT-CAD and AF have a higher prevalence of cardiovascular-related comorbidities, lower BP control rate, and lower use of oral anticoagulation